Epitalon 3mg: Dosage, Research, and Safety Guide

Epitalon 3mg is a common vial size for this synthetic peptide. Learn about typical research dosages, half-life, reconstitution, and safety considerations.

ARTICLE OVERVIEW

Epitalon 3mg is a common vial size for this synthetic peptide. Learn about typical research dosages, half-life, reconstitution, and safety considerations.

Epitalon 3mg is a 3-milligram dose or vial size of epitalon, a synthetic tetrapeptide studied for its potential effects on telomerase and aging. Epitalon is not approved by the FDA for human use, and researchers typically work with it as a laboratory compound. This article explains what epitalon 3mg is, how it is used in research, and what safety and legal considerations apply.

What Is Epitalon 3mg?

Epitalon is a synthetic tetrapeptide made of four amino acids: alanine, glutamic acid, aspartic acid, and glycine. It is also spelled epithalon and was developed by Russian researcher Vladimir Khavinson. The "3mg" refers to the amount of peptide in a vial, which is a common size sold by research chemical vendors.

Epitalon is not a drug approved by the FDA, and it is not a dietary supplement. It is a research chemical intended for laboratory use only. Epitalon is often discussed alongside other synthetic peptides, but that does not change its legal and regulatory status.

How Epitalon 3mg Is Used in Research

In laboratory settings, epitalon 3mg is typically reconstituted with bacteriostatic water before use. Proper epitalon peptide reconstitution involves adding a specific volume of solvent to achieve the desired concentration. For example, adding 1.5 mL of water to a 3mg vial yields a 2 mg/mL solution.

The epitalon half life is short, estimated at a few minutes to a few hours in the body. Because of this, some research protocols involve multiple daily administrations or sustained-release formulations.

Most epitalon peptide research has been conducted in animal models and cell cultures. Studies have explored its effects on telomerase, melatonin production, and oxidative stress. However, human data is very limited.

Epitalon 3mg vs. Other Common Dosages

Epitalon is sold in several vial sizes, and the 3mg dose is one of the smallest. The table below compares common epitalon dosages used in research settings.

DosageTypical Research ContextReconstitution ExampleNotes
3mgSmall pilot studies, single-dose experimentsAdd 1.5 mL bacteriostatic water for 2 mg/mLGood for initial testing or when limited material is needed
5mgMulti-day protocols, repeated measuresAdd 2.5 mL for 2 mg/mLMost common size for research
10mgLarger studies, longer durationsAdd 5 mL for 2 mg/mLMay require larger solvent volumes

Researchers choose a dosage based on the study design, the number of subjects, and the duration of the experiment. A 3mg vial is often sufficient for small pilot studies or single-dose experiments.

What Research Suggests About Epitalon

Some studies in rodents suggest that epitalon may influence melatonin production, antioxidant activity, and lifespan. Media sometimes calls epitalon an anti-aging breakthrough, but that label is not supported by rigorous clinical trials.

Some early studies have explored epitalon peptide cancer interactions, but the evidence is preliminary and mixed. Researchers sometimes study thymalin epitalon together because both are thymus-derived peptides with immunomodulatory effects.

Some researchers hypothesize that epitalon works by activating telomerase, an enzyme that extends telomeres. Telomeres are protective caps on chromosomes that shorten with age. However, telomerase activation is a double-edged sword because it is also associated with cancer cell growth.

No large-scale human trials have confirmed epitalon's anti-aging effects. The existing research is mostly small, short-term, and conducted in animals or cells.

Epitalon is not FDA-approved for human use in the United States. It is sold as a research chemical, not as a drug or supplement. Legal status varies by country, and in the US it is not a controlled substance but is not legal for human consumption.

Side effects of epitalon in humans are not well characterized. Some users report injection site reactions, dizziness, or fatigue, but these are anecdotal. Anyone considering epitalon should consult a healthcare professional.

Because epitalon is a research chemical, quality and purity can vary between suppliers. Researchers should obtain a certificate of analysis and use proper laboratory safety procedures.

Epitalon is not FDA-approved for human use in the United States, and no large-scale clinical trials have confirmed its anti-aging effects.

Key Takeaways

  • Epitalon 3mg is a common vial size for a synthetic peptide studied in aging research.
  • Epitalon is not FDA-approved for human use, and human safety data is lacking.
  • The epitalon half life is short, so dosing schedules in research may involve multiple administrations.
  • Proper epitalon peptide reconstitution is essential for accurate dosing.
  • No rigorous clinical trials support epitalon as an anti-aging treatment.

Frequently Asked Questions

What is epitalon 3mg used for?

In research, epitalon 3mg is used to study telomerase activation, aging, and oxidative stress. It is not approved for human use, so any human application is off-label and not recommended without medical supervision.

How do you reconstitute epitalon 3mg?

To reconstitute epitalon 3mg, add bacteriostatic water to the vial. For example, adding 1.5 mL yields a concentration of 2 mg/mL. Swirl gently; do not shake, as this can damage the peptide.

Is epitalon 3mg safe?

Epitalon 3mg is not FDA-approved for human use, and its safety profile in humans is not well established. Some people report side effects like dizziness or injection site reactions, but data is limited. Consult a healthcare professional before considering it.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.